STATE STREET CORP - NPS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$91,665,000
+40.3%
2,562,576
+2.0%
0.01%
+28.6%
Q3 2014$65,343,000
-7.5%
2,513,231
+17.5%
0.01%
-12.5%
Q2 2014$70,664,000
+3.6%
2,138,056
-6.2%
0.01%0.0%
Q1 2014$68,198,000
-32.8%
2,278,596
-59.6%
0.01%
+33.3%
Q4 2013$101,479,000
+29.8%
5,641,711
+129.5%
0.01%
-40.0%
Q3 2013$78,199,000
+85.4%
2,458,362
-12.0%
0.01%
+100.0%
Q2 2013$42,172,0002,792,5770.01%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders